专利保护的口腔癌药物的潜在替代剂量策略
Austin Wesevich1, Liam J Schmitt2, Mark J Ratain3
1Section of Hematology/Oncology, University of Chicago, Chicago, IL, United States.
概括
超过一半的口服瘤药物可能有替代剂量来降低成本和副作用. 进一步的试验可以证实这些发现,以获得更好的患者和付款人的结果.
科学领域:
- 在瘤学瘤学.
- 药物经济学 药物经济学
- 药物开发 药物开发
背景情况:
- 专利保护的口腔瘤药物代表了医疗保健方面的重大支出.
- 优化剂量策略可以节省大量的成本.
- 减少患者的副作用是癌症治疗的一个关键目标.
研究的目的:
- 确定专利保护的口腔瘤药物的替代剂量策略.
- 评估成本降低的潜力,而不会影响有效性.
- 为未来的营销后优化试验和临床实践提供信息.
主要方法:
- 审查了FDA (2004-2024) 批准的90种口服瘤药物.
- 评估了出版物,摘要和FDA审查潜在的替代剂量策略.
- 根据证据水平 (RCT,非RCT,药理学数据) 分类策略,并计算潜在的成本节约.
主要成果:
- 确定了50个 (56%) 潜在的节省成本的替代剂量策略.
- 平均最大的潜在成本节约为50% (范围为20%-86%).
- 潜在的全球支出每年减少201亿欧元; 索托拉西布和里博西基利布支持立即修改.
结论:
- 超过50%的受专利保护的口腔瘤药物具有潜在的节省成本的剂量策略.
- 这些策略可以降低付款人的成本和患者的副作用.
- 公共支付者和医疗保健系统应该考虑推销后的试验,以优化剂量.
更多相关视频
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.7K
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
12.1K
相关概念视频
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Drug Delivery: Enteral Route
1.6K
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
1.6K
Dosage Regimen: Individualization
166
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
166
